Last reviewed · How we verify
NCT04554368
A Novel Score to Predict Risk of Symptomatic Intracerebral Hemorrhage
trial testing intra-arterial contrast enhanced Flat Detector CT in Intracerebral Hemorrhage in 300 participants. Completed in 30 March 2020.
31 December 2019
Quick facts
| Lead sponsor | Shanghai Jiao Tong University Affiliated Sixth People's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 June 2015 |
| Primary completion | 31 December 2019 |
| Estimated completion | 30 March 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- intra-arterial contrast enhanced Flat Detector CT
Conditions studied
- Intracerebral Hemorrhage — all drugs for Intracerebral Hemorrhage →
- Thrombectomy — all drugs for Thrombectomy →
- Stroke — all drugs for Stroke →
Sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Who can join
18 and older, any sex, with Intracerebral Hemorrhage or Thrombectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study sought to develop and validate a new risk stratification score (Henan predicting the risk of intracerebral hemorrhage score, Henan-PRIHS) based on intra-arterial contrast enhanced Flat Detector CT (IA-CEFDCT) to predict symptomatic intra-cerebral hemorrhage (sICH) after stroke thrombectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04554368
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intracerebral Hemorrhage
Currently open trials in the same condition.
- NCT07458880 — Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control · NA · recruiting
- NCT07365150 — Precision Use of TXA in Intracerebral Hemorrhage · NA · recruiting
- NCT07246473 — Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage · NA · recruiting
- NCT07455201 — Evaluating a Prototype CT Scan for ICH Evacuation · NA · recruiting
- NCT07187687 — TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage · NA · recruiting
Other Shanghai Jiao Tong University Affiliated Sixth People's Hospital trials
Trials by the same sponsor.
- NCT07382063 — Effects of Extra-fascial Interscalene Brachial Plexus Block on Diaphragmatic Function in School-Aged Children · NA · enrolling by invitation
- NCT07278232 — Research on a Machine Learning-Based Predictive Model for Difficult Intubation Using Specific Vocal Characteristics · not yet recruiting
- NCT07171502 — AI-Assisted Ultrasound-Guided Nerve Block: Model Development and Performance Assessment · NA · completed
- NCT07133451 — Multimodal Imaging Evaluation of Vulnerability of Atherosclerotic Plaques: A Comparison of HR-VWI, OCT, and RWS · not yet recruiting
- NCT07125339 — High-resolution Magnetic Resonance Vessel Wall Imaging of Plaques · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04554368 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Jiao Tong University Affiliated Sixth People's Hospital
- Last refreshed: 24 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04554368.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing